Brussels (Brussels Morning Newspaper) – The European Commission has launched a new platform for biotechnology and biologics production to back innovative firms.
The platform will allow companies to identify and access EU support to assist them develop and grow. According to the Commission, the Biotechnology and Biologics Platform will help businesses, particularly start-ups and SMEs, to bring innovative products to the European Union market and boost their competitiveness.
The Biotechnology and Biologics Platform, hosted on the EU Commission’s Your Europe portal, will function as an operational instrument to provide simple and accessible data on relevant EU legislation, funding prospects, and business support networks.
It further integrates biotechnology as one of its prioritized sectors so that investors and project promoters can easily access funding opportunities in strategic technologies. The aim would be to strengthen technological sovereignty and support projects that contribute to the green and digital transformation of the EU.
What role does the EU Commission play in biotech growth?
The European Commission has been undertaking actions to promote biotechnology and biomanufacturing in the EU, especially in its Communication entitled
“Building the Future with Nature: Boosting Biotechnology and Biomanufacturing in the EU,”
which was published on March 20, 2024.
By this, the Commission sought to improve public and private investments in biotechnology by providing various funding instruments including Horizon Europe, the Circular Bio-based Europe Joint Undertaking (CBE JU), and the Strategic Technologies for Europe Platform (STEP). This will help innovate with scaling up and contribute to SMEs.
The Biotechnology and Biologics Platform is the flagship of the Commission to promote biotechnology and biologics in the EU. Today, biotechnology is seen as one of the fastest-growing innovative industries within the EU, with its effective revolutionization of health, agriculture, food, feed, and industry in Europe over the coming years. Building a more competitive, innovative, and resilient EU requires a thriving biotechnology and biologics sector to succeed in both its green and digital transitions.
